Dejarlo, Armando .

HRN: 29-27-96  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
CEFTAZIDIME 1GM (VIAL)
07/09/2026
07/16/2026
IV
2g
Q8
Cap Mr
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines